McKesson | MCK - Ebit

Aktienkurs
747.23
Täglich Wechseln
10.05 1.36%
Monatlich
-13.46%
Jährlich
5.73%
Q2 Prognose
720.85




Ebit Veränderung Datum
Acadia Healthcare USD 83.84M 36.19M 2026-03
Align Technology USD 178.05M 46.66M 2026-03
Cardinal Health USD 861M 98M 2026-03
Centene USD 2.26B 3.5B 2026-03
Charles River Laboratories USD 119.9M 44.08M 2026-03
Cigna USD 2.76B 583M 2026-03
Community Health Systems USD 295M 31M 2025-12
Computer Programs Systems USD -119.41M 121.59M 2025-12
CVS Health USD 4.68B 2.57B 2026-03
DaVita Healthcare Partners USD 473.55M 110.66M 2026-03
Dentsply International USD 32M 506M 2026-03
eHealth USD -44.34M 103.7M 2024-09
Elevance Health USD -5.81B 6.39B 2026-03
Encompass Health USD 319.1M 35.7M 2026-03
HCA USD 2.86B 216M 2026-03
Henry Schein USD 194M 8M 2026-03
Humana USD 1.75B 2.56B 2026-03
IQVIA Holdings USD 565M 2.11B 2026-03
J&J USD 6.62B 1.51B 2026-03
Laboratory Of America USD 410.1M 28.1M 2026-03
McKesson USD 1.84B 181M 2026-03
Molina Healthcare USD 83M 236M 2026-03
Owens Minor USD 814K 28.08M 2025-12
Quest Diagnostics USD 399M 13M 2026-03
Stryker USD 1.1B 867M 2026-03
Tenet Healthcare USD 1.38B 509M 2026-03
UnitedHealth USD 9.04B 5.78B 2026-03
Universal Health Services USD 502.86M 14.37M 2026-03
Veradigm USD -45.47M 70.47M 2022-12